ZA891402B - 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion - Google Patents
4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretionInfo
- Publication number
- ZA891402B ZA891402B ZA891402A ZA891402A ZA891402B ZA 891402 B ZA891402 B ZA 891402B ZA 891402 A ZA891402 A ZA 891402A ZA 891402 A ZA891402 A ZA 891402A ZA 891402 B ZA891402 B ZA 891402B
- Authority
- ZA
- South Africa
- Prior art keywords
- qyuinoline
- acyl
- inhibitors
- derivatives
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888804444A GB8804444D0 (en) | 1988-02-25 | 1988-02-25 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA891402B true ZA891402B (en) | 1990-09-26 |
Family
ID=10632376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA891402A ZA891402B (en) | 1988-02-25 | 1989-02-23 | 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion |
Country Status (22)
Country | Link |
---|---|
US (1) | US5089504A (pt) |
EP (1) | EP0330485B1 (pt) |
JP (1) | JPH0774204B2 (pt) |
KR (1) | KR0159083B1 (pt) |
CN (2) | CN1027368C (pt) |
AU (1) | AU606508B2 (pt) |
CA (1) | CA1332839C (pt) |
CZ (1) | CZ398391A3 (pt) |
DE (1) | DE68906687T2 (pt) |
DK (1) | DK166623B1 (pt) |
ES (1) | ES2055037T3 (pt) |
FI (1) | FI93952C (pt) |
GB (1) | GB8804444D0 (pt) |
HU (1) | HU208814B (pt) |
IE (1) | IE63239B1 (pt) |
IL (1) | IL89346A (pt) |
MY (1) | MY105158A (pt) |
NZ (1) | NZ228098A (pt) |
PT (1) | PT89789B (pt) |
WO (1) | WO1989008104A1 (pt) |
ZA (1) | ZA891402B (pt) |
ZW (1) | ZW1989A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
DK0480052T3 (da) * | 1990-03-28 | 1998-05-11 | Otsuka Pharma Co Ltd | Quinolinderivat, antiulcus-lægemiddel indeholdende derivatet og fremstilling af derivatet |
CA2099117A1 (en) * | 1991-01-29 | 1992-07-30 | Robert John Ife | Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
SE9302005D0 (sv) | 1993-06-11 | 1993-06-11 | Ab Astra | New active compounds |
EP1086094A1 (en) | 1998-05-23 | 2001-03-28 | Byk Gulden Lomberg Chemische Fabrik GmbH | Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
HN2000000203A (es) | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
WO2003043614A2 (en) * | 2001-11-19 | 2003-05-30 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
AU2003254282A1 (en) | 2002-08-01 | 2004-02-23 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
MXPA04008070A (es) | 2003-03-10 | 2004-11-26 | Altana Pharma Ag | Novedoso proceso para la preparacion de roflumilasto. |
WO2005041961A1 (en) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
JP5383183B2 (ja) * | 2005-03-16 | 2014-01-08 | タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロフルミラストを含有する矯味された剤形 |
CN106496119A (zh) * | 2016-10-17 | 2017-03-15 | 江南大学 | 一种n‑苯基‑8‑氨基喹啉的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2652398A (en) * | 1949-11-17 | 1953-09-15 | Endo Products Inc | N-substituted-2-amino (methyl) quinolines |
US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
CA942748A (en) * | 1970-09-18 | 1974-02-26 | Venkatachala L. Narayanan | 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds |
ZA801526B (en) * | 1979-03-26 | 1981-08-26 | Robins Co Inc A H | 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds |
US4343804A (en) * | 1979-03-26 | 1982-08-10 | A. H. Robins Company, Inc. | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
-
1988
- 1988-02-25 GB GB888804444A patent/GB8804444D0/en active Pending
-
1989
- 1989-02-20 KR KR1019890701954A patent/KR0159083B1/ko not_active IP Right Cessation
- 1989-02-20 WO PCT/EP1989/000175 patent/WO1989008104A1/en active IP Right Grant
- 1989-02-20 ZW ZW19/89A patent/ZW1989A1/xx unknown
- 1989-02-20 AU AU31819/89A patent/AU606508B2/en not_active Ceased
- 1989-02-20 HU HU891463A patent/HU208814B/hu not_active IP Right Cessation
- 1989-02-20 IL IL8934689A patent/IL89346A/en not_active IP Right Cessation
- 1989-02-20 JP JP1502451A patent/JPH0774204B2/ja not_active Expired - Lifetime
- 1989-02-21 MY MYPI89000210A patent/MY105158A/en unknown
- 1989-02-21 CA CA000591638A patent/CA1332839C/en not_active Expired - Fee Related
- 1989-02-22 NZ NZ228098A patent/NZ228098A/xx unknown
- 1989-02-22 PT PT89789A patent/PT89789B/pt not_active IP Right Cessation
- 1989-02-23 US US07/314,726 patent/US5089504A/en not_active Expired - Lifetime
- 1989-02-23 ES ES89301804T patent/ES2055037T3/es not_active Expired - Lifetime
- 1989-02-23 EP EP89301804A patent/EP0330485B1/en not_active Expired - Lifetime
- 1989-02-23 DE DE89301804T patent/DE68906687T2/de not_active Expired - Fee Related
- 1989-02-23 ZA ZA891402A patent/ZA891402B/xx unknown
- 1989-02-23 IE IE56889A patent/IE63239B1/en not_active IP Right Cessation
- 1989-02-24 CN CN89100929A patent/CN1027368C/zh not_active Expired - Fee Related
- 1989-10-24 FI FI895048A patent/FI93952C/fi not_active IP Right Cessation
- 1989-10-24 DK DK528889A patent/DK166623B1/da not_active IP Right Cessation
-
1991
- 1991-12-20 CZ CS913983A patent/CZ398391A3/cs unknown
-
1994
- 1994-02-26 CN CN94102353A patent/CN1100414A/zh active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA891402B (en) | 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion | |
EG18128A (en) | Process for preparation of substituted thienoimidazole derivatives and their use as inhibitors of gastric acid secretion | |
EP0532466A3 (en) | Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use | |
NZ224361A (en) | Preparation of (6s)-folinic acid and its salts | |
HU9202085D0 (en) | Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid | |
EP0421946A3 (en) | 3-indolepyruvic acid derivatives their method of production and therapeutic use | |
EP0273689A3 (en) | Derivatives of n-(2-alkyl-3-mercapto-glutaryl) alpha-amino acids and their use as collagenase inhibitors | |
HU893412D0 (en) | Inhibitors of interleucin-1 | |
ZA891439B (en) | 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion | |
IL89534A0 (en) | Preparation of 1-cyclopropyl-quinolone-carboxylic acids and derivatives thereof and certain novel n-cyclopropyl-anilines used therein | |
ZA891442B (en) | Heteroaryl 1-amino-3-acyquinoline derivatives and their use as inhibitors of gastric secretion | |
ZA855030B (en) | Benzimadzoles,benzoxales,benzothiazoles and their production,formulation and use as gastric acid secretion inhibitors | |
GB2205745B (en) | Use of dioxopiperidine derivatives as analgesics | |
HU9302201D0 (en) | Salts of 4-amino-3-acyl-quinoline derivatives and their application for hindering secretion of gastric acid | |
AU7465487A (en) | Benzimidazole derivatives and their use as gastric acid secretion inhibitors | |
NZ217322A (en) | Toluidine derivatives and gastric acid inhibitor compositions | |
DE3666826D1 (en) | Human natural inhibitor of collagenases | |
AU3494293A (en) | Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors | |
ZA891441B (en) | 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion | |
YU146288A (en) | Derivatives of benzimidazole-2-il-pyridinium | |
ZA929568B (en) | 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion | |
AU582255B2 (en) | Embonates of quinolonecarboxylic acids and of their derivatives | |
IL87428A0 (en) | Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors | |
ZA867827B (en) | Benzimadazoles,benzoxazoles,benzothiazoles and their production,formulation and use as gastric acid secretion inhibitors | |
GB2206579B (en) | 6a and 6b-(substituted methyl)-penicillanic acid derivatives |